World Imaging Agents Market to Reach US$10.4 Billion by 2010, According to New Report by Global Industry Analysts, Inc.

San Jose, CA (PRWEB) July 9, 2007 -- Development of contrast agents revolutionized the visualization of organs within the human body. With their inherent ability to bring discrete organs and tissues to investigational scrutiny, imaging agents have undergone immense changes. Technology developments over the last two decades have expanded application roles of imaging agents. Major imaging technologies that presently utilize imaging agents include - x-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), ultrasound technologies. X-ray contrast media is paving way for emerging segments such as MRI, Ultrasound and diagnostic radiopharmaceuticals. Reimbursement issues and procedural volumes are two key factors that exert a significant impact on market dynamics.

"Imaging Agents: A Global Strategic Business Report" provides a comprehensive review of market trends, drivers, challenges, product profile, players, competition, regulatory framework, technological developments, research and development activity, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as United States, Japan, France, Germany, the UK, Italy, Asia, Latin America and the Middle East. Value analytics are provided in terms of product segments including Contrast Media (X-ray imaging agents, MRI imaging agents and Ultrasound imaging agents) and Diagnostic Radiopharmaceuticals.

Demand for imaging agents moves in sync with diagnosis and management of several age-related diseases including cancer, cardiovascular disease, and neurological disease. United States is the largest imaging agents market worldwide at an estimated US$3.3 billion in 2007. Japan is the second largest market followed by Europe. The US, Japan and Europe together account for about 88 percent of the global share. The three are among the fastest growing markets with CAGRs ranging between 7% and 11% through 2010. The X-ray contrast media market is the largest segment estimated at US$4.2 billion in 2007. The http://www.strategyr.com/MCP-3336.asp) is projected to reach US$3.4 billion by 2010.

">diagnostic radiopharmaceuticals market (http://www.strategyr.com/MCP-3336.asp) is projected to reach US$3.4 billion by 2010.

The global marketplace is relatively concentrated and characterized by several well-established players. Leading market participants include Advanced Magnetics, Alliance Pharmaceutical, Amersham, Biomira Inc, Bracco Group, Bristol-Myers Squibb, Cytogen Corp, Daiichi Sankyo Company, Dowpharma, Eisai Co, EPIX Pharmaceutical, E-Z-EM Inc, Guerbet Group, Immunomedics Inc, Schering AG and Tyco Healthcare.

For more details about this research report, please visit www.strategyr.com/MCP-3336.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) (http://www.strategyr.com) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Email press(at)StrategyR.com

Web Site www.StrategyR.com

###